MDT
88.44
-0.16%ā
VEEV
284.2
+0.67%ā
A
121.49
+1.08%ā
WBA
11.47
-0.09%ā
HQY
101.96
+0.85%ā
MDT
88.44
-0.16%ā
VEEV
284.2
+0.67%ā
A
121.49
+1.08%ā
WBA
11.47
-0.09%ā
HQY
101.96
+0.85%ā
MDT
88.44
-0.16%ā
VEEV
284.2
+0.67%ā
A
121.49
+1.08%ā
WBA
11.47
-0.09%ā
HQY
101.96
+0.85%ā
MDT
88.44
-0.16%ā
VEEV
284.2
+0.67%ā
A
121.49
+1.08%ā
WBA
11.47
-0.09%ā
HQY
101.96
+0.85%ā
MDT
88.44
-0.16%ā
VEEV
284.2
+0.67%ā
A
121.49
+1.08%ā
WBA
11.47
-0.09%ā
HQY
101.96
+0.85%ā
24u
Huidig
Min
1.86
Max
1.9
Aanbevelingen | Buy |
---|---|
12 Maanden Prognose | +431.91% upside |
Volgende Winsten | 11 aug 2025 |
---|
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
10 mrt 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Lezen
10 mrt 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Lezen
10 mrt 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Lezen
10 mrt 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Lezen
10 mrt 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Lezen
10 mrt 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Lezen
10 mrt 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Lezen
Prijswijziging
By TipRanks
12 Maanden Prognose
Gemiddelde 10Ā USDĀ 431.91%
Hoogste 16Ā USD
Laagste 4Ā USD
Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Fortress Biotech Inc - Dist. in de afgelopen 3 maanden.
By TipRanks
Buy
2 ratings
2
Buy
0
Hold
0
Sell
Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Fortress Biotech Inc - Dist in de afgelopen 3 maanden.
$